Clinical Consulting K/S: Financial statements 2022
CVR: 38863797
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Clinical Consulting K/S (CVR 38863797) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 1,626,602 and a net result of DKK 56,087 compared with DKK 247,907 the year before. That is an increase of 19% compared with the year before. The profit margin was 3.4%. Equity in the 2022 report amounted to DKK 476,389. The solvency ratio was 99.5%.
- Revenue
- DKK 1,626,602
- Gross Profit
- DKK 1,424,557
- Profit/Loss
- DKK 56,087
- Equity
- DKK 476,389
- Total Assets
- DKK 478,838
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 1.6M | 1.4M | 56K | 476K | - |
| 2021 | 1.4M | 1.2M | 248K | 420K | - |
| 2020 | 1.7M | 1.5M | -22K | 172K | - |
| 2019 | 1.6M | 1.4M | -114K | 194K | - |
Official annual report
Keep an eye on Clinical Consulting K/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Clinical Consulting K/S has published its annual report for 2021. Revenue came to DKK 1,366,585, and the net result was DKK 247,907.
About Clinical Consulting K/S
Clinical Consulting K/S was a Danish company of the type Kommanditselskab based in Farum, founded in 2017. The company has been dissolved on 6 February 2025. The company was registered under the industry Virksomhedsrådgivning og andre rådgivningsaktiviteter. In 2023, the company reported revenue of DKK 969,972 and a net result of DKK 33,551 compared with DKK 56,087 the year before. Equity in the 2023 report amounted to DKK 309,940.
